Actionable news
All posts from Actionable news
Actionable news in REGN: Regeneron Pharmaceuticals, Inc.,

Regeneron: Time to Sell?

Regeneron Pharmaceuticals (REGN) had been on fire this year--and then Sanofi (SNY) reported earnings yesterday.

Illustration: Pixabay

What does Sanofi have to do with Regeneron? Plenty. Regeneron and Sanofi have developed a number of drugs together--Leerink's Geoffrey Porges went as far as calling them "joined at the hip" in a note released last night-- including Dupixent, an eczema treatment. And yesterday, Sanofi reported that sales of Dupixent...